Search Results

High-quality cytokines for organoid growth, differentiation, and expansion.

The new digital platform reinforces CELLnTEC’s positioning as the pioneer in chemically defined, animal-free tissue culture and a leader in epithelial and skin tissue engineering.

Invikafusp alfa, a first-in-class dual T cell agonist, showed an objective response in various types of cancer, particularly among patients who did not respond to previous checkpoint inhibitor therapy.

In this episode of Denatured, you’ll hear from Diana Saraceni, founder and managing partner at Panakès Partners and Fabrizio Calisti, medical director at Angelini Ventures. We explore how Italy’s life sciences ecosystem has evolved over the last decade—from stronger tech transfer and growing venture capital to the gaps that still keep it from matching the UK, Germany or France in company creation and scale.